Xerava

Chemical Nameeravacycline
Dosage FormInjection (intravenous; 1 mg/kg, 1.5 mg/kg)
Drug ClassTetracyclines
SystemDigestive
CompanyTetraphase Pharmaceuticals Inc.
Approval Year2018

Indication

  • For treatment of complicated intra-abdominal infections in adults ≥18 years of age.
Last updated on 11/11/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Xerava (Eravacycline) Prescribing Information 2018Tetraphase Pharmaceuticals Inc, Watertown, MA